Symbiosis Capital Partners, Llc Portfolio Stock Holdings
According to the SEC 13F filed on May 12, 2026, Symbiosis Capital Partners, Llc disclosed 5 stock positions valued at approximately $52.77M as of quarter-end March 31, 2026. The largest holdings include Evommune, Inc., Inventiva S.A., and Rani Therapeutics Holdings, Inc..
- Report Period
- March 31, 2026
- No. of Stocks
- 5
- Portfolio Value
- $52.77M
Holdings by Sector
Symbiosis Capital Partners, Llc Portfolio Holdings in Q1 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Evommune, Inc. | EVMN | Healthcare | 55.80% | 1,280,778 | - | - | $29,445,086 |
| Inventiva S.A. | IVA | Healthcare | 24.76% | 2,354,000 | -246,000 | -9.46% | $13,064,700 |
| Rani Therapeutics Holdings, Inc. | RANI | Healthcare | 5.11% | 3,667,585 | -2,632,415 | -41.78% | $2,694,941 |
| Clene Nanomedicine Inc. | CLNN | Consumer Defensive | 4.03% | 431,094 | -339,401 | -44.05% | $2,125,293 |
| Surrozen, Inc. | SRZNW | Healthcare | 0.00% | 150,000 | - | - | $2,400 |
Showing 5 of 5 holdings in the latest reporting period.